Gisela Cálas
Articles
GMP Compliance for Production of CB.Hep-1 Monoclonal Antibody as a Biological Reagent
María del Rosario Alemán;Cristina García;Andrés Tamayo;Gisela Cálas;Marcos González;Maria del Carmen Abrahantes-Pérez;José A Montero;Rodolfo Valdés;Tatiana Alvarez;Biunayki Reyes
February 1st 2006Development guidelines for MAbs serve as a blueprint for their manufacture, safety, and efficacy testing.
Latest Updated Articles
Published: October 11th 2024 | Updated: March 3rd 2025
Exploring New Advancements in ADC Technologies (CPHI Milan 2024)
Published: September 11th 2024 | Updated: September 18th 2024
CPHI Pharma Award Finalists Announced for 2024
Published: March 27th 2024 | Updated: June 28th 2024
AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product
Published: July 25th 2025 | Updated: July 31st 2025
Trade Policy Shifts: Compliance and Cost Strategies for Pharma
Published: July 28th 2025 | Updated: July 31st 2025
AstraZeneca’s Imfinzi Advances in Gastric Cancer With FDA Priority Review
Published: July 21st 2025 | Updated: July 31st 2025
Video Interview With Chris Hagen, President of SCIEX
